Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -TRY 164.9B, followed by BridgeBio Pharma (-TRY 105.2B) and Cytokinetics (-TRY 33.3B). Figures as of 18 Nov 2026, 15:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-TRY 164.9B
- Median
- TRY 44.3B
- Combined market value
- TRY 256.39T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -TRY 164.9B | TRY 25.69T | TRY 14,535.15 | 1.58% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -TRY 105.2B | TRY 763.3B | TRY 3,918.37 | 1.16% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -TRY 33.3B | TRY 361.1B | TRY 2,592.41 | 0.48% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -TRY 10.4B | TRY 254.6B | TRY 3,047.85 | 0.12% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -TRY 9.1B | TRY 896.6B | TRY 13,668.66 | 0.07% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -TRY 6.1B | TRY 262.9B | TRY 6,229.60 | 1.69% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -TRY 3.6B | TRY 379.6B | TRY 1,089.42 | 2.27% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | TRY 4.5B | TRY 351.5B | TRY 6,683.28 | 2.53% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | TRY 5.8B | TRY 242.9B | TRY 2,530.63 | 1.81% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 7B | TRY 407.1B | TRY 5,871.76 | 0.16% down | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | TRY 15.9B | TRY 300.9B | TRY 4,608.84 | 0.62% down | 31% up | ||
| 12 | ErascaERAS · Health Care | TRY 16.4B | TRY 232.9B | TRY 663.74 | 5.26% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | TRY 16.8B | TRY 197.2B | TRY 1,440.45 | 2.79% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 23.5B | TRY 310.3B | TRY 2,194.72 | 1.22% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | TRY 23.8B | TRY 329.6B | TRY 4,860.01 | 0.04% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | TRY 24.7B | TRY 228.6B | TRY 1,372.87 | 0.96% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | TRY 24.9B | TRY 245.9B | TRY 4,367.00 | 0.45% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | TRY 25.5B | TRY 370.2B | TRY 4,228.81 | 2.13% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | TRY 26.3B | TRY 225.3B | TRY 2,058.29 | 2.93% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 28.6B | TRY 380.2B | TRY 4,838.83 | 0.87% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 30.4B | TRY 485B | TRY 20,879.25 | 1.90% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | TRY 31B | TRY 410.2B | TRY 6,285.34 | 0.04% down | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | TRY 32.1B | TRY 249.7B | TRY 1,434.90 | 2.15% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | TRY 32.7B | TRY 377.2B | TRY 3,446.29 | 2.48% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | TRY 32.7B | TRY 486.3B | TRY 3,217.32 | 1.72% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | TRY 33.2B | TRY 436.4B | TRY 545.72 | 1.41% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | TRY 36.1B | TRY 456.4B | TRY 4,806.17 | 1.58% up | 286% up | ||
| 28 | InsmedINSM · Health Care | TRY 37.3B | TRY 1.32T | TRY 6,033.91 | 1.83% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | TRY 38.9B | TRY 324.6B | TRY 7,992.59 | 0.48% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | TRY 39.8B | TRY 1.04T | TRY 7,734.87 | 2.01% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | TRY 44.3B | TRY 431B | TRY 15,420.31 | 0.22% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | TRY 50.5B | TRY 158.9B | TRY 819.08 | 0.81% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | TRY 51.3B | TRY 300.8B | TRY 15,039.26 | 1.49% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | TRY 91.8B | TRY 394.4B | TRY 2,346.79 | 2.38% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | TRY 168B | TRY 1.72T | TRY 4,224.27 | 0.33% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 202.4B | TRY 630.3B | TRY 756.04 | 1.35% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 217.8B | TRY 786.3B | TRY 12,249.39 | 0.90% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | TRY 220B | TRY 2.33T | TRY 20,399.35 | 2.13% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | TRY 228.3B | TRY 1.42T | TRY 1,966.50 | 0.72% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | TRY 294.9B | TRY 1.6T | TRY 2,597.20 | 0.89% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | TRY 295B | TRY 292.6B | TRY 429.97 | 1.22% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | TRY 307B | TRY 586.4B | TRY 3,027.67 | 2.60% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | TRY 330.2B | TRY 664B | TRY 1,328.48 | 1.90% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | TRY 357.9B | TRY 1.23T | TRY 28,898.70 | 1.90% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 398.9B | TRY 2.5T | TRY 2,141.77 | 0.36% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | TRY 490B | TRY 1.99T | TRY 3,457.64 | 0.18% down | 78% up | ||
| 47 | ViatrisVTRS · Health Care | TRY 742B | TRY 1.2T | TRY 1,044.78 | 1.30% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | TRY 931.7B | TRY 6.19T | TRY 3,026.16 | 2.20% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | TRY 941.4B | TRY 6.81T | TRY 26,867.26 | 0.28% down | 27% up | ||
| 50 | GSKGSK · Health Care | TRY 1.1T | TRY 4.94T | TRY 2,465.31 | 0.73% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | TRY 1.34T | TRY 62.42T | TRY 70,081.10 | 1.84% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | TRY 1.45T | TRY 8.82T | TRY 2,000.29 | 2.56% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | TRY 1.58T | TRY 4.99T | TRY 48,230.95 | 0.15% down | 36% up | ||
| 54 | NovartisNVS · Health Care | TRY 2.33T | TRY 14.91T | TRY 7,892.73 | 1.66% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | TRY 2.35T | TRY 3.44T | TRY 1,076.99 | 1.32% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | TRY 2.45T | TRY 13.99T | TRY 9,023.00 | 1.85% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | TRY 2.63T | TRY 9.07T | TRY 5,238.54 | 0.81% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | TRY 2.65T | TRY 17.36T | TRY 7,040.87 | 2.63% down | 51% up | ||
| 59 | SanofiSNY · Health Care | TRY 3.99T | TRY 5.73T | TRY 2,384.61 | 0.53% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | TRY 4.11T | TRY 33.37T | TRY 13,863.35 | 1.37% down | 38% up | ||
| 61 | PfizerPFE · Health Care | TRY 4.36T | TRY 8.1T | TRY 1,421.29 | 1.02% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4360 TRY).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-TRY 164.9B), BridgeBio Pharma (-TRY 105.2B) and Cytokinetics (-TRY 33.3B) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:56 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of TRY 256.39T as of 18 Nov 2026, 15:56 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.